Takeda Pharmaceutical Company Limited
METHOD TO PRODUCE A HIGHLY CONCENTRATED IMMUNOGLOBULIN PREPARATION FOR SUBCUTANEOUS USE
Last updated:
Abstract:
The present invention relates to a new and improved method for preparing a highly concentrated immunoglobulin composition from pooled plasma for subcutaneous injection. A composition comprising 20% or more immunoglobulin suitable for subcutaneous use is also described.
Status:
Application
Type:
Utility
Filling date:
31 Jan 2022
Issue date:
19 May 2022